BridgeMD
New treatment option for Rotator Cuff Tendinopathy
Official title Effect of Adding Extracorporeal Shock Wave Therapy to Exercises in Rotator Cuff Tendinopathy
ClinicalTrials.gov ID: NCT07390396
What this study is testing
- What it's testing
- Rotator cuff tendinopathy (RCT) is one of the most common causes of shoulder pain, resulting in functional limitations and reduced quality of life. Exercise therapy is considered a first-line treatment; however, adjunct modalities such as extracorporeal shock wave therapy (ESWT) may enhance recovery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 55
You may be able to join if
- Medically stable individuals who consent to participate in the study.
- Male and female participants aged between 30 and 55 years.
- Diagnosed with rotator cuff tendinopathy, confirmed clinically and by ultrasound or MRI.
- Duration of symptoms greater than 3 months.
- Supraspinatus tendon thickness \> 5.85 mm as measured by ultrasound (based on Hunter et al., 2021).
You likely can't join if
- Massive rotator cuff tear or complete tendon rupture.
- Adhesive capsulitis or significant limitation of passive shoulder motion.
- History of shoulder fracture, dislocation, or surgery in the affected limb.
- Rheumatoid arthritis, diabetes mellitus, or systemic inflammatory disease.
- Cervical radiculopathy or neurological involvement affecting the shoulder.
- Corticosteroid injection in the affected shoulder within the last 6 months.
See the full eligibility criteria
- Medically stable individuals who consent to participate in the study.
- Male and female participants aged between 30 and 55 years.
- Diagnosed with rotator cuff tendinopathy, confirmed clinically and by ultrasound or MRI.
- Duration of symptoms greater than 3 months.
- Supraspinatus tendon thickness \> 5.85 mm as measured by ultrasound (based on Hunter et al., 2021).
- Able to follow the treatment plan and attend all therapy sessions.
- Massive rotator cuff tear or complete tendon rupture.
- Adhesive capsulitis or significant limitation of passive shoulder motion.
- History of shoulder fracture, dislocation, or surgery in the affected limb.
- Rheumatoid arthritis, diabetes mellitus, or systemic inflammatory disease.
- Cervical radiculopathy or neurological involvement affecting the shoulder.
- Corticosteroid injection in the affected shoulder within the last 6 months.
- Pregnancy or breastfeeding.
- BMI \> 30 kg/m² (obese individuals excluded).
- Current malignancy, open wounds, or local infection at the treatment site.
- Inability to tolerate shock wave therapy or perform exercise sessions.
The study team makes the final eligibility decision.
Where it's taking place
- Minya, Menia Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minya, Menia Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.